1-溴环戊烷羧酸乙酯 | 30038-94-9

• 物质功能分类: 化学试剂 - 有机试剂 - 酯类
• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 中文名称: 1-溴环戊烷羧酸乙酯
• 英文名称: ethyl 1-bromocyclopentanecarboxylate
• 英文别名: 1-bromocyclopentane-carboxylic acid ethyl ester；ethyl 1-bromocyclopentane-1-carboxylate
• CAS: 30038-94-9
• 化学式: C₈H₁₃BrO₂
• 分子量: 221.094
• InChiKey: HKNNXQUAMZHIER-UHFFFAOYSA-N

物化性质

• 沸点：
  219.7±23.0 °C(Predicted)
• 密度：
  1.420±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.3
• 重原子数：
  11
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.88
• 拓扑面积：
  26.3
• 氢给体数：
  0
• 氢受体数：
  2

安全信息

• 海关编码：
  2916209090

反应信息

• 作为反应物：
  描述：

  1-溴环戊烷羧酸乙酯 在 氢氧化钾 、 potassium carbonate 、 potassium iodide 作用下， 以 乙醇 为溶剂， 反应 75.0h， 生成 JP-7
  参考文献：
  名称：

  Synthesis and X-ray Studies of Chiral Allosteric Modifiers of Hemoglobin

  摘要：

  This study was designed to investigate the effect of chirality on the allosteric activity of a series of Hb allosteric modifiers. The chiral analogues were based on the lead compound (4), JP7, {1-[4-(((3,5-dimethylanilino)carbonyl)methyl)phenoxy]cyclopentanecarboxylic acid} with different D- and L-amino acids conjugated to the JP7 acid moiety. The D-isomers were the most potent in vitro effectors in Hb solutions as well as with whole blood. In general, this study demonstrated that the chirality of extended amino acid side chains in JP7 conjugates plays an important role in observed degree of allosteric activity. The binding site interactions for four analogues were determined by single crystallographic diffraction studies. Conclusions show that the chiral configuration of some of the D-isomers enable the effectors to bind with a greater number of interactions with the protein residues. D- and L-isomers with equivalent or near equivalent allosteric activity did not show any significant differences or interactions between their amino acid side chains and the protein. The most potent effectors, in vitro, were compounds 15 and 19, D-isomers of leucine and phenylalanine, respectively. Compounds 21, 22, 30, and 32 were more potent in vitro in Hb solutions than JP7.

  DOI：

  10.1021/jm010358l
• 作为产物：
  描述：

  环戊酸 在 N-溴代丁二酰亚胺(NBS) 、 硫酸 作用下， 以 四氯化碳 为溶剂， 反应 11.0h， 生成 1-溴环戊烷羧酸乙酯
  参考文献：
  名称：

  Synthesis and X-ray Studies of Chiral Allosteric Modifiers of Hemoglobin

  摘要：

  This study was designed to investigate the effect of chirality on the allosteric activity of a series of Hb allosteric modifiers. The chiral analogues were based on the lead compound (4), JP7, {1-[4-(((3,5-dimethylanilino)carbonyl)methyl)phenoxy]cyclopentanecarboxylic acid} with different D- and L-amino acids conjugated to the JP7 acid moiety. The D-isomers were the most potent in vitro effectors in Hb solutions as well as with whole blood. In general, this study demonstrated that the chirality of extended amino acid side chains in JP7 conjugates plays an important role in observed degree of allosteric activity. The binding site interactions for four analogues were determined by single crystallographic diffraction studies. Conclusions show that the chiral configuration of some of the D-isomers enable the effectors to bind with a greater number of interactions with the protein residues. D- and L-isomers with equivalent or near equivalent allosteric activity did not show any significant differences or interactions between their amino acid side chains and the protein. The most potent effectors, in vitro, were compounds 15 and 19, D-isomers of leucine and phenylalanine, respectively. Compounds 21, 22, 30, and 32 were more potent in vitro in Hb solutions than JP7.

  DOI：

  10.1021/jm010358l

文献信息

• Construction of Vicinal Quaternary Carbons via Cu-catalyzed Dearomative Radical Addition
  作者：Naoki Tsuchiya、Takashi Nishikata

  DOI：10.1246/cl.190247

  日期：2019.7.5

  In this paper, we confirmed the dearomative addition of tertiary alkyl radicals onto BHT derivatives to form highly congested vicinal quaternary carbons to produce tert-alkylated styrenes in the pr...

  在本文中，我们证实了叔烷基与 BHT 衍生物的脱芳基加成形成高度拥挤的邻位季碳，从而在制备过程中产生叔烷基化苯乙烯。
• 作为URAT1抑制剂的噻吩类衍生物
  申请人：江苏艾立康医药科技有限公司

  公开号：CN109608432B

  公开（公告）日：2022-10-11

  本发明涉及作为URAT1抑制剂的噻吩类衍生物。具体而言，本发明涉及一种通式(I)所示噻吩类衍生物及其可药用盐，及其制备方法以及它们作为URAT1抑制剂，特别是作为尿酸水平异常相关的病症的治疗剂的用途。
• CYCLOALKYL ACID DERIVATIVE, PREPARATION METHOD THEREOF, AND PHARMACEUTICAL APPLICATION THEREOF
  申请人：SHANGHAI HENGRUI PHARMACEUTICAL CO., LTD.

  公开号：US20160108035A1

  公开（公告）日：2016-04-21

  Cycloalkyl acid derivatives, a preparation method thereof, and a pharmaceutical application thereof are described. In particular, a cycloalkyl acid derivative represented by general formula (I) and a medical salt thereof, a preparation method thereof, and an application of the cycloalkyl acid derivative and the medical salt thereof as URAT1 inhibitors, and particularly as therapeutic agents for diseases related to an abnormal uric acid level are described, wherein definitions of substituent groups in general formula (I) are the same as the definitions in the specification.

  描述了环烷基酸衍生物及其制备方法和药物应用。具体地，描述了一种由通式（I）表示的环烷基酸衍生物及其医用盐，其制备方法，以及将该环烷基酸衍生物和医用盐作为URAT1抑制剂的应用，特别是作为治疗与异常尿酸水平相关疾病的药物。其中，通式（I）中取代基团的定义与说明书中的定义相同。
• 사이클로알킬산 유도체, 그의 제조 방법, 및 그의 약학적 용도
  申请人：SHANGHAI HENGRUI PHARMACEUTICAL CO., LTD. 샹하이 헨그루이 파마수티컬 컴퍼니 리미티드(520080332544)

  公开号：KR20160006207A

  公开（公告）日：2016-01-18

  본 발명은 사이클로알킬산 유도체, 그의 제조 방법 및 그의 약학적 용도에 관한 것이며, 특히 본 발명은 하기 화학식 I에 의해 나타내는 사이클로알킬산 유도체 및 그의 의학적 염, 그의 제조 방법, 및 URAT1 억제제로서 및 특히 이상 요산 수준과 관련된 질병에 대한 치료제로서 상기 사이클로알킬산 유도체 및 그의 의학적 염의 용도에 관한 것이며, 여기에서 화학식 I의 치환체 그룹들의 정의는 명세서에서의 정의와 같다. 화학식 I

  这是一段关于某种环丙基酸衍生物的专利描述，涉及其制备方法和药用用途，特别是涉及由化学式I表示的环丙基酸衍生物及其医药盐、制备方法，以及作为URAT1抑制剂和特别是用于治疗与高尿酸水平相关的疾病的药物的用途。在此，化学式I中的取代基团的定义与规范中的定义相同。 化学式I
• Catalytic Cyclopropanol Ring Opening for Divergent Syntheses of γ-Butyrolactones and δ-Ketoesters Containing All-Carbon Quaternary Centers
  作者：Zhishi Ye、Xinpei Cai、Jiawei Li、Mingji Dai

  DOI：10.1021/acscatal.8b00711

  日期：2018.7.6

  cyclopropanol ring opening cross couplings with 2-bromo-2,2-dialkyl esters. Our mechanistic studies reveal that unlike the previously reported cases, the formation of α,β-unsaturated enone intermediates is actually essential for the γ-butyrolactone synthesis and also contributes to the formation of the δ-ketoester product. The γ-butyrolactone synthesis is proposed to go through an intermolecular radical conjugate

  粗环丙醇的催化开环交叉偶联反应可用于合成各种β-取代的羰基产物。在这些开环交叉偶联反应中，α,β-不饱和烯酮副产物的形成经常与所需的交叉偶联过程竞争，并且一直是一个有待解决的具有挑战性的合成问题。在此，我们描述了我们通过铜催化环丙醇开环与2-溴-2,2-二烷基酯的开环交叉偶联，开发多种含有全碳季中心的γ-丁内酯和δ-酮酯的不同合成方法。我们的机理研究表明，与之前报道的情况不同，α,β-不饱和烯酮中间体的形成实际上对于γ-丁内酯的合成至关重要，并且也有助于δ-酮酯产物的形成。 γ-丁内酯的合成建议通过分子间自由基共轭加成到原位生成的α,β-不饱和烯酮上，然后通过分子内自由基环化成酯羰基双键。该反应可有效构建全碳四元中心，并具有广泛的底物范围。